Drawing based on the label description. No photo yet.
“Ofloxacin tablets USP, 400 mg are available as yellow to dark yellow, oval, biconvex, film coated tablets, imprinted with 'C211' in blue ink on one side and plain on other side”
C211 pill
Pill with imprint C211 is yellow, oval, 19 mm and has been identified as Ofloxacin 400 mg. It is used for H. pylori infection, bronchitis and urinary tract infections (UTIs). It is supplied by Cadila Pharmaceuticals Limited.
Ofloxacin 400 mg
- Imprint
- C211
- Strength
- 400 mg
- Used for
- H. pylori infection, bronchitis and urinary tract infections (UTIs)
- Color
- Yellow
- Shape
- Oval
- Size
- 19 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Cadila Pharmaceuticals Limited
- Drug class
- Antibiotic (fluoroquinolone)
- NDC
- 71209-099, 71209-099-02, 71209-099-05, 71209-099-10, 72241-074, 72241-074-02, 72241-074-05, 72241-074-10
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Ofloxacin used for?
Ofloxacin is used for H. pylori infection, bronchitis, urinary tract infections (UTIs) and skin infections.
- Medicine type
- Antibiotic (fluoroquinolone)
Official uses from the US prescribing label
To reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets, USP and other antibacterial drugs, ofloxacin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ofloxacin tablets, USP are indicated for the treatment of adults with mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the designated microorganisms in the infections listed below. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) due to Haemophilus influenzae or Streptococcus pneumoniae.
Because fluoroquinolones, including ofloxacin, have been associated with serious adverse reactions (see Warnings ), -and for some patients ABECB is self-limiting, reserve ofloxacin for treatment of ABECB in patients who have no alternative treatment options. Community-Acquired Pneumonia due to Haemophilus influenzae or Streptococcus pneumoniae.
Uncomplicated Skin and Skin Structure Infections due to methicillin-susceptible Staphylococcus aureus, Streptococcus pyogenes, or Proteus mirabilis. Acute, Uncomplicated Urethral and Cervical Gonorrhea due to Neisseria gonorrhoeae (see WARNINGS ). Nongonococcal Urethritis and Cervicitis due to Chlamydia trachomatis (see WARNINGS ). Mixed Infections of the Urethra and Cervix due to Chlamydia trachomatis and Neisseria gonorrhoeae (see WARNINGS ). Acute Pelvic Inflammatory Disease (including severe infection) due to Chlamydia trachomatis and/or Neisseria gonorrhoeae (see WARNINGS ). NOTE: If anaerobic microorganisms are suspected of contributing to the infection, appropriate therapy for anaerobic pathogens should be administered. Uncomplicated Cystitis due to Citrobacter diversus, Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Pseudomonas aeruginosa. Because fluoroquinolones, including ofloxacin, have been associated with serious adverse reactions (see WARNINGS ), and for some patients uncomplicated cystitis is self-limiting, reserve ofloxacin for treatment of uncomplicated cystitis in patients who have no alternative treatment options. Complicated Urinary Tract Infections due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Citrobacter diversus,* or Pseudomonas aeruginosa.*
Prostatitis due to Escherichia coli. * = Although treatment of infections due to this organism in this organ system demonstrated a clinically significant outcome, efficacy was studied in fewer than 10 patients.
Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to ofloxacin, USP. Therapy with ofloxacin, USP may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. As with other drugs in this class, some strains of Pseudomonas aeruginosa may develop resistance fairly rapidly during treatment with ofloxacin, USP. Culture and susceptibility testing performed periodically during therapy will provide information not only on the therapeutic effect of the antimicrobial agent but also on the possible emergence of bacterial resistance.
From the FDA-approved label on DailyMed (published Jun 23, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows C211 and the other side is plain.
- It is yellow, oval, 19 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Ofloxacin
Inactive: Lactose Monohydrate, Starch, Corn, Hypromellose 2910 (5 Mpa.s), Sodium Starch Glycolate Type A Potato, Talc, Magnesium Stearate, Polyethylene Glycol 400, Titanium Dioxide, Ferric Oxide Yellow, Hypromelloses, Fd&c Blue No. 1, Isopropyl Alcohol, Butyl Alcohol, Propylene Glycol, Shellac
Also distributed by
Modavar Pharmaceuticals LLC
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 13 and 9
Oxcarbazepine 600 mg
Yellow, oval, 19 mm
Used for focal seizures
-
656 P
Zileuton 600 mg
Yellow, oval, 20 mm
Used for asthma
-
537
Potassium Citrate 10 mEq
Yellow, oval, 19 mm
Used for low potassium and renal tubular acidosis
-
D 63
Clarithromycin 500 mg
Yellow, oval, 18 mm
Used for ulcers and H. pylori infection
-
E 11
Levetiracetam 500 mg
Yellow, oval, 18 mm
Used for focal seizures and tonic-clonic seizures
-
G 13 9
Oxcarbazepine 600 mg
Yellow, oval, 19 mm
Used for focal seizures